Syndax Pharmaceuticals (NASDAQ:SNDX) is scheduled to announce Q4 earnings results on Monday, March 3rd, before market open. The consensus EPS Estimate is -$0.23 (+77.0% Y/Y) and the consensus Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback